These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 21437891)

  • 41. Concurrent chemoradiotherapy for T4 patients with hypopharyngeal and laryngeal squamous cell carcinomas.
    Nishimura G; Tsukuda M; Horiuchi C; Satake K; Yoshida T; Nagao J; Kawakami M; Kondo N; Arai Y; Taguchi T; Matsuda H; Mikami Y
    Auris Nasus Larynx; 2007 Dec; 34(4):499-504. PubMed ID: 17604583
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Induction chemotherapy improved outcomes of patients with resectable esophageal cancer who received chemoradiotherapy followed by surgery.
    Jin J; Liao Z; Zhang Z; Ajani J; Swisher S; Chang JY; Jeter M; Guerrero T; Stevens CW; Vaporciyan A; Putnam J; Walsh G; Smythe R; Roth J; Yao J; Allen P; Cox JD; Komaki R
    Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):427-36. PubMed ID: 15380576
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Intensity-modulated radiation treatment for head-and-neck squamous cell carcinoma--the University of Iowa experience.
    Yao M; Dornfeld KJ; Buatti JM; Skwarchuk M; Tan H; Nguyen T; Wacha J; Bayouth JE; Funk GF; Smith RB; Graham SM; Chang K; Hoffman HT
    Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):410-21. PubMed ID: 16168834
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Management of stage IV glottic carcinoma: therapeutic outcomes.
    Spector GJ; Sessions DG; Lenox J; Newland D; Simpson J; Haughey BH
    Laryngoscope; 2004 Aug; 114(8):1438-46. PubMed ID: 15280724
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Radiochemotherapy versus surgery plus radio(chemo)therapy for stage T3/T4 larynx and hypopharynx cancer - results of a matched-pair analysis.
    Rades D; Schroeder U; Bajrovic A; Schild SE
    Eur J Cancer; 2011 Dec; 47(18):2729-34. PubMed ID: 21726998
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Primary Surgery vs Chemoradiation Treatment of Advanced-Stage Hypopharyngeal Squamous Cell Carcinoma.
    Harris BN; Biron VL; Donald P; Farwell DG; Luu QC; Bewley AF; Chen AM; Daly ME
    JAMA Otolaryngol Head Neck Surg; 2015 Jul; 141(7):636-40. PubMed ID: 25973578
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Laryngeal preservation for advanced laryngeal and hypopharyngeal cancers.
    Clayman GL; Weber RS; Guillamondegui O; Byers RM; Wolf PF; Frankenthaler RA; Morrison WH; Garden AS; Hong WK; Goepfert H
    Arch Otolaryngol Head Neck Surg; 1995 Feb; 121(2):219-23. PubMed ID: 7840931
    [TBL] [Abstract][Full Text] [Related]  

  • 48. EGR1 regulates radiation-induced apoptosis in head and neck squamous cell carcinoma.
    Yoon TM; Kim SA; Lee DH; Lee JK; Park YL; Lee KH; Chung IJ; Joo YE; Lim SC
    Oncol Rep; 2015 Apr; 33(4):1717-22. PubMed ID: 25710185
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [A retrospective study on combined modality therapy with or without surgery for advanced hypopharyngeal squamous cell carcinoma: an analysis of 119 cases].
    Zhang YX; Peng HH; Zhang XX; Zhao JD; Wu WM; Wang JL; Huang DL; Zong L; Chen LW; Liu CQ; Liu MB
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2018 May; 53(5):352-358. PubMed ID: 29764016
    [No Abstract]   [Full Text] [Related]  

  • 50. Larynx preservation: what is the best non-surgical strategy?
    Lagha A; Chraiet N; Labidi S; Rifi H; Ayadi M; Krimi S; Allani B; Raies H; Touati S; Boussen H; Kochbati L; Mezlini A
    Crit Rev Oncol Hematol; 2013 Nov; 88(2):447-58. PubMed ID: 23755889
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Treatment, comorbidity and survival in stage III laryngeal cancer.
    Connor KL; Pattle S; Kerr GR; Junor E
    Head Neck; 2015 May; 37(5):698-706. PubMed ID: 24596316
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Clinical study and survival analysis of combined modality therapies for advanced hypopharyngeal carcinoma].
    Shi Q; Li W; Li G; Zhang C; Fang X; Wu L; Zhang L; Liao Z
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2013 Feb; 27(4):206-9. PubMed ID: 23631137
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Long-term outcomes of induction chemotherapy followed by chemoradiotherapy using volumetric-modulated arc therapy as an organ preservation approach in patients with stage IVA-B oropharyngeal or hypopharyngeal cancers.
    Kubo K; Murakami Y; Kenjo M; Imano N; Takeuchi Y; Nishibuchi I; Kimura T; Kawahara D; Ueda T; Takeno S; Nagata Y
    J Radiat Res; 2020 Jul; 61(4):554-562. PubMed ID: 32548612
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Patients with locally advanced hypopharyngeal carcinoma. Results over a 30-year period.
    León X; López M; García J; Rovira C; Casasayas M; Quer M
    Acta Otorrinolaringol Esp (Engl Ed); 2019; 70(6):315-326. PubMed ID: 30527320
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Concurrent chemoradiotherapy improves survival in patients with hypopharyngeal cancer.
    Paximadis P; Yoo G; Lin HS; Jacobs J; Sukari A; Dyson G; Christensen M; Kim H
    Int J Radiat Oncol Biol Phys; 2012 Mar; 82(4):1515-21. PubMed ID: 21658855
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Laryngo-esophageal dysfunction free survival and propensity score matched analysis comparing organ preservation and total laryngectomy in hypopharynx cancer.
    Petersen JF; Arends CR; van der Noort V; Al-Mamgani A; de Boer JP; Stuiver MM; van den Brekel MWM
    Oral Oncol; 2019 Aug; 95():143-149. PubMed ID: 31345382
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cetuximab and Radiotherapy in Laryngeal Preservation for Cancers of the Larynx and Hypopharynx: A Secondary Analysis of a Randomized Clinical Trial.
    Bonner J; Giralt J; Harari P; Spencer S; Schulten J; Hossain A; Chang SC; Chin S; Baselga J
    JAMA Otolaryngol Head Neck Surg; 2016 Sep; 142(9):842-9. PubMed ID: 27389475
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Local response to chemoradiation in T4 larynx cancer with cartilage invasion.
    Patel UA; Howell LK
    Laryngoscope; 2011 Jan; 121(1):106-10. PubMed ID: 21120838
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Locally advanced hypopharyngeal and laryngeal cancer: Influence of HPV status.
    Bates JE; Morris CG; Hitchcock KE; Dziegielewski PT; Mendenhall WM; Amdur RJ
    Radiother Oncol; 2019 Nov; 140():6-9. PubMed ID: 31174105
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Treatment Selection for T3/T4a Laryngeal Cancer: Chemoradiation Versus Primary Surgery.
    Timme DW; Jonnalagadda S; Patel R; Rao K; Robbins KT
    Ann Otol Rhinol Laryngol; 2015 Nov; 124(11):845-51. PubMed ID: 25991835
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.